Cargando…
Identification of Genetic Mutations in Cancer: Challenge and Opportunity in the New Era of Targeted Therapy
The introduction of targeted therapy is the biggest success in the treatment of cancer in the past few decades. However, heterogeneous cancer is characterized by diverse molecular alterations as well as multiple clinical profiles. Specific genetic mutations in cancer therapy targets may increase dru...
Autores principales: | Jin, Jing, Wu, Xu, Yin, Jianhua, Li, Mingxing, Shen, Jing, Li, Jing, Zhao, Yueshui, Zhao, Qijie, Wu, Jingbo, Wen, Qinglian, Cho, Chi Hin, Yi, Tao, Xiao, Zhangang, Qu, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477148/ https://www.ncbi.nlm.nih.gov/pubmed/31058077 http://dx.doi.org/10.3389/fonc.2019.00263 |
Ejemplares similares
-
Increased ABCC4 Expression Induced by ERRα Leads to Docetaxel Resistance via Efflux of Docetaxel in Prostate Cancer
por: Huang, Houbao, et al.
Publicado: (2020) -
Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons
por: Zhao, Qijie, et al.
Publicado: (2021) -
m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer
por: Zhao, Yueshui, et al.
Publicado: (2019) -
Protective Role of γδ T Cells in Different Pathogen Infections and Its Potential Clinical Application
por: Zhao, Yueshui, et al.
Publicado: (2018) -
Carboranes as unique pharmacophores in antitumor medicinal chemistry
por: Chen, Yu, et al.
Publicado: (2022)